Long-lived CA RHIO shuts down
The Santa Barbara County (Calif.) Care Data Exchange has closed, brought down by a mix of funding issues and privacy concerns. The Exchange, which was perhaps the oldest RHIO in the country, was launched in 1998 with $10 million in funding from the California Healthcare Foundation. While Exchange members had figured out how to share information securely, the organizations involved were still concerned about their legal liability in the event that the data fell into the wrong hands, according to former acting chairman Robert Reid. Also, the group was struggling with paying for operating costs, including the cost of building filters which would hold back sensitive information from being seen by other RHIO participants. With the Exchange closing, the California Healthcare Foundation is considering turning the RHIO software into an open source product.
To learn more about the closure:
- read this piece from Government Health IT
Related Articles:
Network lets CA med groups locate records. Report
A solution for RHIO privacy issues: EHR/EMR "banking." Editorial
Philly RHIO users visit competing providers. Report
Be the first to comment
Comments
By Mark Singh MD | Posted 8:51pm | September 28, 2007
I believe the failure of these highly funded RHIOs, such as the Santa Barbara RHIO, highlight the fallacy of "design-by-committee" method of creating such organizations.
RHIOs will start to succeed once they act as businesses that focus on sustainable models that meet true business needs rather than the needs decided by committees. They will need to adopt a "start-up" model, depend less on government funding (handouts), and rely more on self-funding and private investments.
Mark Singh MD
www.Clinicore.blogspot.com
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies